Clinical Trial: A Multicenter Real-World Study on the Treatment of Moderate-to-Severe Atopic Dermatitis in Chinese Adults with Spesolimab (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter Real-World Study on the Treatment of Moderate-to-Severe Atopic Dermatitis in Chinese Adults with Spesolimab'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130135

Registration Time: 2026/08/15

Type: Observational study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336650

Published by HT Digital Content Services with permission from Health Daily Digest....